These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Heinrichs RW Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745 [No Abstract] [Full Text] [Related]
3. The costs of drugs for schizophrenia. Freedman R; Carpenter WT; Davis JM; Goldman HH; Tamminga CA; Thomas M Am J Psychiatry; 2006 Dec; 163(12):2029-31. PubMed ID: 17151146 [No Abstract] [Full Text] [Related]
4. Pretrial medication bias in randomized antipsychotic drug trials. Leucht S; Heres S; Hamann J; Kissling W Am J Psychiatry; 2007 Aug; 164(8):1266; author reply 1266-7. PubMed ID: 17671291 [No Abstract] [Full Text] [Related]
5. Lessons from each drug trial. Marder SR Am J Psychiatry; 2007 Mar; 164(3):375-6. PubMed ID: 17329457 [No Abstract] [Full Text] [Related]
6. Switch or stay? Davis JM; Marder SR; Tamminga CA Am J Psychiatry; 2006 Dec; 163(12):2032-3. PubMed ID: 17151147 [No Abstract] [Full Text] [Related]
7. Clinical trials during the prodromal stage of schizophrenia. Addington J; Addington D Am J Psychiatry; 2005 Jul; 162(7):1387. PubMed ID: 15994732 [No Abstract] [Full Text] [Related]
8. Challenge to atypical antipsychotic drug effect on cognition. Carpenter WT; Conley RR Am J Psychiatry; 2007 Dec; 164(12):1910-1; author reply 1911-2. PubMed ID: 18056250 [No Abstract] [Full Text] [Related]
12. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia. Woods SW; Gueorguieva RV; Baker CB; Makuch RW Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728 [TBL] [Abstract][Full Text] [Related]
13. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease]. Naber D; Lambert M; Karow A Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315 [TBL] [Abstract][Full Text] [Related]
15. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets. Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786 [TBL] [Abstract][Full Text] [Related]
16. Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). Kane JM J Clin Psychiatry; 2006 May; 67(5):831-2. PubMed ID: 16841634 [No Abstract] [Full Text] [Related]